Literature DB >> 12888911

Genomic structure and mutational analysis of the human KIF1Balpha gene located at 1p36.2 in neuroblastoma.

Yu Yan Chen1, Junko Takita, Ying Zhang Chen, Hong Wei Yang, Ryoji Hanada, Keiko Yamamoto, Yasuhide Hayashi.   

Abstract

KIF1a is a member of the kinesin superfamily proteins that are microtubule-dependent molecular motors involved in important intracellular functions such as organelle transport and cell division. We previously determined the structure of the human KIF1Bbeta gene, which was found to be a homologue of the murine Kif1bbeta, and demonstrated that the human KIF1Bbeta is a causative gene of Charcot-Marie-Tooth disease type 2A although we did not prove that it is a tumor suppressor gene of neuroblastoma. Here, we identified another isoform of the human KIF1B gene, KIF1Balpha. The KIF1Balpha and KIF1Bbeta are alternative splicing products of the KIF1B gene located on 1p36.2. The KIF1Balpha is distinct from KIF1Bbeta in the C-terminal cargo-binding domain; however, they have the same N-terminal motor domain. We found that the transcript of approximately 7.8 kb of KIF1Balpha was expressed in several tissues, especially in skeletal muscle, by Northern blot analysis. To determine whether this gene is one of the candidate tumor suppressor genes for neuroblastoma (NB) or other pediatric solid tumors, we performed mutational screening of KIF1Balpha in 25 NB, 9 rhabdomyosarcoma, 12 Ewing sarcoma and 24 other pediatric solid tumor cell lines. Using RT-PCR single-strand conformation polymorphism analysis and direct sequencing we detected a missense mutation (M807I) in 1 NB cell line (SK-N-SH), 3 silent mutations in 2 NB cell lines and 1 primitive neuroectodermal tumor cell line, respectively. RT-PCR analysis revealed that KIF1Balpha was obviously expressed in almost all of the tumor cell lines examined except NB-1. Furthermore, real-time quantitative RT-PCR showed that there was no significant difference in KIF1Balpha expression between 14 early-stage (stage I and II) and 14 advanced-stage (stage III and IV) NB fresh tumor specimens. These results suggest that KIF1Ba in addition to KIF1Bbeta may not be a candidate tumor suppressor gene for NB.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12888911

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  Polymorphisms in the kinesin-like factor 1 B gene and risk of epithelial ovarian cancer in Eastern Chinese women.

Authors:  Ting-Yan Shi; Zhi Jiang; Rong Jiang; Sheng Yin; Meng-Yun Wang; Ke-Da Yu; Zhi-Ming Shao; Meng-Hong Sun; Rongyu Zang; Qingyi Wei
Journal:  Tumour Biol       Date:  2015-04-09

2.  Genetic polymorphism of the kinesin-like protein KIF1B gene and the risk of hepatocellular carcinoma.

Authors:  Zhi-Chao Wang; Qiang Gao; Jie-Yi Shi; Liu-Xiao Yang; Jian Zhou; Xiao-Ying Wang; Ying-Hong Shi; Ai-Wu Ke; Guo-Ming Shi; Zhen-Bin Ding; Zhi Dai; Shuang-Jian Qiu; Jia Fan
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

3.  Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status.

Authors:  Xiang Guo; Qing-Rong Chen; Young K Song; Jun S Wei; Javed Khan
Journal:  BMC Med Genomics       Date:  2011-04-18       Impact factor: 3.063

4.  The novel protein KBP regulates mitochondria localization by interaction with a kinesin-like protein.

Authors:  Marcin J Wozniak; Martina Melzer; Cornelia Dorner; Hans-Ulrich Haring; Reiner Lammers
Journal:  BMC Cell Biol       Date:  2005-10-14       Impact factor: 4.241

5.  Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.

Authors:  Katarina Ejeskär; Cecilia Krona; Helena Carén; Faten Zaibak; Lingli Li; Tommy Martinsson; Panayiotis A Ioannou
Journal:  BMC Cancer       Date:  2005-12-16       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.